nach oben

Diabetologia

Erschienen in:

01.01.2009 | For Debate

Preventing hypoglycaemia: what is the appropriate glucose alert value?

verfasst von: P. E. Cryer

Erschienen in: Diabetologia | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Excerpt

Everyone is entitled to their own opinion, but not their own facts.

Daniel Patrick Moynihan

…

Swinnen SGHA, Mullins P, Miller M, Hoekstra JBL, Holleman F (2009) Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia doi:10.1007/s00125-008-1147-0

Frier BM (2009) Defining hypoglycaemia: what level has clinical relevance? Diabetologia doi:10.1007/s00125-008-1209-3

Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in type 2 diabetes. Diabet Med 25:245–254PubMedCrossRef

American Diabetes Association Workgroup on Hypoglycemia (2005) Defining and reporting hypoglycemia in diabetes. Diabetes Care 28:1245–1249CrossRef

The Diabetes Research in Children Network (DirecNet) Study Group (2003) A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther 5:933–941CrossRef

Cryer PE (2001) The prevention and correction of hypoglycemia. In: Jefferson LS, Cherrington AD (eds) Handbook of physiology, Section 7, the endocrine system. Volume II, the endocrine pancreas and regulation of metabolism. Oxford University Press, New York, pp 1057–1092

Schwartz NS, Clutter WE, Shah SD, Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777–781PubMedCrossRef

Mitrakou A, Ryan C, Veneman T et al (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol Endocrinol Metab 260:E67–E74

Fanelli C, Pampanelli S, Epifano L et al (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797–807PubMedCrossRef

10.

Davis SN, Shavers C, Mosqueda-Garcia R, Costa F (1997) Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328–1335PubMedCrossRef

11.

Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV (1988) Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901–907PubMedCrossRef

12.

Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318:1487–1492PubMedCrossRef

13.

Cox DJ, Gonder-Frederick L, Ritterbrand L, Clarke W, Kovatchev BP (2007) Prediction of severe hypoglycemia. Diabetes Care 30:1370–1373PubMedCrossRef

14.

Committee for Proprietary Medicinal Products of the European Agency for the Evaluation of Medicinal Products (2008) Note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus. Available from: http://www.emea.europa.eu/pdfs/human/ewp/108000en.pdf, accessed 29 May 2008

15.

Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes. doi:10.2337/db08-1084

16.

Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J (1992) Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia 35:958–961PubMedCrossRef

17.

Heine RJ (1993) Methods of investigation of insulin-induced hypoglycaemia. In: Frier BM, Fisher BM (eds) Hypoglycaemic in diabetes: clinical and physiological aspects. Arnold, London, pp 165–175

Titel: Preventing hypoglycaemia: what is the appropriate glucose alert value?
verfasst von: P. E. Cryer
Publikationsdatum: 01.01.2009
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 1/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-008-1205-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Preventing hypoglycaemia: what is the appropriate glucose alert value?

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits

Trends in cardiovascular admissions and procedures for people with and without diabetes in England, 1996–2005

Insulin sensitivity measured by the euglycaemic insulin clamp and proinsulin levels as predictors of stroke in elderly men

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial

Combined thiazolidinedione–metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle

Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin